Anbok Lee

990 citations
42 papers · 694 indexed · h-index 13

Impact in

    • Cancer, Hypoxia, and Metabolism
    • Cancer, Lipids, and Metabolism
    • Cancer Immunotherapy and Biomarkers

Papers in

Anbok Lee

40 papers receiving 686 citations

Peers

Anbok Lee
Comparison fields: 5 of 100
  • Cancer Research 128
  • Oncology 192
  • Immunology 139
  • Pulmonary and Respiratory Medicine 165
  • Gastroenterology 25
Replace Chris Tsopelas with:
Chris Tsopelas Australia
Oleg I. Kit Russia
Kejun Zhang China
Zhenzhen Yao China
Haohai Zhang China
Zhiguo Luo China
Heng Lu United States
Ping Sun China
Bishnuhari Paudyal Japan
Yao Xie China
Anbok Lee relative to Chris Tsopelas Australia Chris Tsopelas's profile →
Citations per field
00.5×6.9×
Chris Tsopelas · 1×
Citations per year

Countries citing papers authored by Anbok Lee

Since Specialization
Citations

This map shows the geographic impact of Anbok Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anbok Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anbok Lee more than expected).

Fields of papers citing papers by Anbok Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anbok Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anbok Lee. The network helps show where Anbok Lee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anbok Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anbok Lee Line = papers co-authored together Anbok Lee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20254
2 20231
3 20211
4 202111
5 202111
6 20209
7 202010
8 201979
9 20199
10 201817
11 20184
12 20179
13 201616
14 20166
15 20157
16 201477
17 20127
18 201215
19 201127
20 201178

About Anbok Lee

Anbok Lee is a scholar working on Cancer Research, Biological Psychiatry, Oncology, Dermatology and Nephrology, having authored 42 papers that have together received 694 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Treatment and Pharmacology (4 papers) and Breast Implant and Reconstruction (3 papers). The work is most often cited by research in Cancer Research (128 citations), Oncology (192 citations), Immunology (139 citations), Pulmonary and Respiratory Medicine (165 citations) and Gastroenterology (25 citations). Anbok Lee has collaborated with scholars based in South Korea, United States and Hong Kong. Frequent co-authors include Tae Hyun Kim, Byung-In Moon, Sumin Chae, Joo‐Ho Lee, Woosung Lim, Dong‐Hyun Kim, Ji Won Park, Hyeon Kook Lee, Ju‐Young Seoh and Jeong Hae Kie. Their work appears in journals such as PLoS ONE, Breast Cancer, The Breast Journal, Annals of Laboratory Medicine and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026